Literature DB >> 12845681

Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India.

Rengaswamy Sankaranarayanan1, Ramani Wesley, Somanathan Thara, Namrata Dhakad, Bharathykutty Chandralekha, Paul Sebastian, K Chithrathara, Donald Maxwell Parkin, Madhavan Krishnan Nair.   

Abstract

Simple and inexpensive methods based on visual examination of the cervix are currently being investigated as alternative methods of cervical screening. The test characteristics of visual inspection with 4% acetic acid (VIA), and Lugol's iodine (VILI) and conventional cytology were investigated in a cross-sectional study involving 4,444 women aged 25 to 65 years in Kerala, India. While detection of any acetowhite area constituted a low-threshold positive VIA, detection of well-defined, opaque acetowhite lesions close to or touching the squamocolumnar junction constituted a high-threshold positive VIA test. Detection of definite yellow iodine nonuptake areas in the transformation zone close to or touching the squamocolumnar junction constituted a positive VILI test. Cytology was considered positive if reported as atypia or worse lesions. All screened women were evaluated by colposcopy and biopsies were directed in 1,644 women (37.0%), which allowed the direct estimation of sensitivity, specificity and predictive values. The reference diagnosis was based on a combination of histology and/or colposcopy. True disease status was defined as CIN 2 and worse lesions. A total of 149 (3.4%) women had CIN 2 or worse lesions. The sensitivities of low-threshold VIA, high-threshold VIA, VILI and cytology to detect CIN 2 or worse disease were 88.6%, 82.6%, 87.2% and 81.9%, respectively; the corresponding specificities were 78.0%, 86.5%, 84.7% and 87.8%. Our results indicate that VIA and VILI are suitable alternate screening tests to cytology for detecting cervical neoplasia in low-resource settings. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845681     DOI: 10.1002/ijc.11245

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  39 in total

1.  Cervical cancer screening in Kolkata, India: beliefs and predictors of cervical cancer screening among women attending a women's health clinic in Kolkata, India.

Authors:  Brita Roy; Tricia S Tang
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

2.  Development of Algorithms for Automated Detection of Cervical Pre-Cancers With a Low-Cost, Point-of-Care, Pocket Colposcope.

Authors:  Mercy Nyamewaa Asiedu; Anish Simhal; Usamah Chaudhary; Jenna L Mueller; Christopher T Lam; John W Schmitt; Gino Venegas; Guillermo Sapiro; Nimmi Ramanujam
Journal:  IEEE Trans Biomed Eng       Date:  2018-12-18       Impact factor: 4.538

3.  Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya.

Authors:  E Were; Z Nyaberi; N Buziba
Journal:  Afr Health Sci       Date:  2011-03       Impact factor: 0.927

Review 4.  Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review.

Authors:  Prajakta Adsul; Nitin Manjunath; Vijaya Srinivas; Anjali Arun; Purnima Madhivanan
Journal:  Cancer Epidemiol       Date:  2017-07-10       Impact factor: 2.984

5.  Hybrid Transfer Learning for Classification of Uterine Cervix Images for Cervical Cancer Screening.

Authors:  Vidya Kudva; Keerthana Prasad; Shyamala Guruvare
Journal:  J Digit Imaging       Date:  2020-06       Impact factor: 4.056

6.  Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings.

Authors:  Jose-Miguel Yamal; Getie A Zewdie; Dennis D Cox; E Neely Atkinson; Scott B Cantor; Calum MacAulay; Kalatu Davies; Isaac Adewole; Timon P H Buys; Michele Follen
Journal:  J Biomed Opt       Date:  2012-04       Impact factor: 3.170

7.  Analysis of the effectiveness of visual inspection with acetic acid/Lugol's iodine in one-time and annual follow-up screening in rural China.

Authors:  Rong Li; Adam K Lewkowitz; Fang-Hui Zhao; Qi Zhou; Shang-Ying Hu; Hui Qiu; Yan Zhang; Hong-Wei Jiang; Jin-Song Zhang; Ming Li; Shao-Min Tong; Qiao-Yu Zhang; You-Lin Qiao
Journal:  Arch Gynecol Obstet       Date:  2012-01-06       Impact factor: 2.344

8.  Cervical cancer prevention in the 21st century: cost is not the only issue.

Authors:  Deborah Maine; Sarah Hurlburt; Dana Greeson
Journal:  Am J Public Health       Date:  2011-07-21       Impact factor: 9.308

9.  Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India.

Authors:  Patti E Gravitt; Proma Paul; Hormuzd A Katki; Haripriya Vendantham; Gayatri Ramakrishna; Mrudula Sudula; Basany Kalpana; Brigitte M Ronnett; K Vijayaraghavan; Keerti V Shah
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

10.  Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology.

Authors:  Adhemar Longatto-Filho; Paulo Naud; Sophie Fm Derchain; Cecília Roteli-Martins; Sílvio Tatti; Luciano Serpa Hammes; Luis Otavio Sarian; Mojca Eržen; Margherita Branca; Jean Carlos de Matos; Renata Gontijo; Marina Y S Maeda; Temístocles Lima; Silvano Costa; Stina Syrjänen; Kari Syrjänen
Journal:  Virchows Arch       Date:  2012-05-05       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.